Hôpital de l'Archet | ClinicalTrials HQ

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis	Metabolic Dysfunction Associated Steatohepatitis	Recruiting	Phase 3	2026-10-01		NCT06632457
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis	Digestive System Diseases, Fibrosis, Fibrosis, Liver, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorder	Recruiting	Phase 3	2026-10-01		NCT06632444
Natural History of Type 1 Interferonopathies: Insights From a European Cohort	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, autoimmune disease, hereditary disease, immune system disorder, nervous system disorder	Recruiting	Not stated	2026-09-10		NCT07040774
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum	Skin Ulcer, Skin and Connective Tissue Diseases, pyoderma, pyoderma gangrenosum, skin disorder, skin vascular disease	Recruiting	Phase 3	2026-09-02		NCT06624670
Effisayil™ ON: A Study to Test Long-term Treatment With Spesolimab in People With Generalized Pustular Psoriasis Who Took Part in a Previous Study	Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, generalized pustular psoriasis, psoriasis, skin disorder	Active, not recruiting	Phase 2	2026-09-01		NCT03886246
Impact on Mortality of a Strategy Including Continuous Positive Airway Pressure Plus High Flow Nasal Cannula Oxygen Therapy Versus High Flow Nasal Cannula Oxygen Therapy Alone in Patients With de Novo Acute Hypoxemic Respiratory Failure: a Prospective, Randomized Controlled Trial.	De Novo Hypoxemic Acute Respiratory Failure (hARF)	Recruiting	Not applicable	2026-04-13		NCT06213168